Chapter 20 Epithelial Sodium Channels in Cystic Fibrosis

Current Topics in Membranes and Transport

Volumn 47, Issue C, 1999, Pages 351-380

  Berdiev, Bakhrom K ^a   Ismailov, Iskander I ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004704752     PISSN: 00702161     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2161(08)60968-5     Document Type: Article

References (140)

1. Adam G., and Delbriick M. Reduction of dimensionality in biological diffusion processes. In: Rich A., and Davidson N. (Eds). "Structural Chemistry and Molecular Biology. (1967), Freeman, San Francisco 198-215
2. Adams C.M., Snyder P.M., and Welsh M.J. Interactions between subunits of the human epithelial sodium channel. J. Biol. Chem. 272 (1997) 27295-27300
3. Aizenbud B.M., and Oershon N.D. Diffusion of molecules on biological membranes of nonplanar form. A theoretical study. Biophys. J. 38 (1982) 287-293
4. Aizenbud B.M., and Gershon N.D. Diffusion of molecules on biological membranes of nonplanar form. II. Diffusion anisotropy. Biophys. J. 48 (1985) 543-546
5. Al-Jader L.N., Meredith A.L., Ryley Cheadle H.C., Maguire J.P.S., Owen G., Goodchild M.C., and Harper P.S. Severity of chest disease in cystic fibrosis patients in relation to their genotypes. J. Med. Genet. 29 (1992) 883-887
6. Alton E.W., Hay J.G., Munro C., and Geddes D.M. Measurement of nasal potential difference in adult cystic fibrosis, Young's syndrome, and bronchiectasis. Thorax 42 (1987) 815-817
7. Alton E.W., Currie D., Logan-Sinclair R., Warner J.O., Hodson M.E., and Geddes D.M. Nasal potential difference: A clinical diagnostic test for cystic fibrosis. Eur. Respir. J. 3 (1990) 922-926
8. Anderson M.P., Gregory R.J., Thompson S., Souza D.W., Paul S., Mulligan Smith R.C.A.E., and Welsh M.J. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253 (1991) 202-205
9. App E.M., King M., Helfesrieder R., Kohler D., and Matthys H. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy. Am. Rev. Respire. Dis. 141 (1990) 605-612
10. + channel. J. Gen. Physiol. 108 (1996) 49-65
11. + channel by its β and γ-subunits. Am. J. Physiol. 42 (1997) C1889-C1899
12. Ballard S.T., Schepens S.M., Falcone J.C., Meininger G.A., and Taylor A.E. Regional bioelectric properties of porcine airway epithelium. J. Appl. Physiol. 73 (1992) 2021-2027
13. Barker P.M., Gowen C.W., Lawson E.E., and Knowles M.R. Decreased sodiumion absorption across nasal epithelium of very premature infants with respiratory distress syndrome. J. Pediatr. 130 (1997) 373-377
14. Berdiev B.K., Prat A.G., Cantiello H.F., Ausiello D.A., Fuller C.M., Jovov B., Benos D.J., and Ismailov I.I. Regulation of epithelial sodium channels by short actin filaments. J. Biol. Chem. 271 (1996) 17704-17710
15. + channel. Biophys. J. 75 (1998) 2292-2301
16. Berg H.C., and Purcell E.M. Physics of chemoreception. Biophys. J. 20 (1977) 193-219
17. Biwersi J., and Verkman A.S. Functions of CFTR other than as a plasma membrane chloride channel. In: Dodge J.A., Brock D.J.H., and Widdicombe J.H. (Eds). "Cystic Fibrosis-Current Topics. 2 (1994), Wiley, Chichester 155-171
18. Biwersi J., Emans N., and Verkman A.S. Cystic fibrosis transmembrane conductance regulator activation stimulates endosome fusion in vivo. Natl. Acad. Scio. U.S.A. 93 (1996) 12484-12489
19. Blank U., Rückes C., Clauss W., Hofmann T., Lindeman H., Munker G., and Weber W.M. Cystic fibrosis and non-cystic fibrosis human nasal epithelium show analogous Na absorbtion and reversible block by phenamil. Pfluegers Arch. 434 (1997) 19-24
20. Boucher R.C. Human airway ion transport. Part 1. Am. J. Respir. Crit. Care Med. 150 (1994) 271-281
21. Boucher R.C. Human airway ion transport. Part 2. Am. J. Respir. Crit. Care Med. 150 (1994) 581-593
22. Boucher Bromberg R.C.P.A., and Gatzy J.T. Airway transepithelial electric potential in vivo: Species and regional differences. J. Appl. Physiol. 48 (1980) 169-176
23. Boucher Stutts R.C.M.J., and Gatzy J.T. Regional differences in bioelectric properties and ion flow in excised canine airways. J. Appl. Physiol. 51 (1981) 706-714
24. + transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J. Clin. Invest. 78 (1986) 1245-1252
25. - or multiple ion transport defects. Prog. Clin. Biol. Res. 254 (1987) 89-100
26. Boucher Yankaskas R.C., Cotton J.R.C.U., Knowles M.R., and Stutts M.J. Cell culture approaches to the investigation of human airway ion transport. Eur. J. Respir. Dis. Suppl. 153 (1987) 59-67
27. + permeability in cystic fibrosis human primary cell cultures. J. Physiol. (London 40 (1988) 77-103
28. Bradbury N.A., Jilling T., Berta G., Sorscher E.J., Bridges R.J., and Kirk K.L. Regulation of plasma membrane recycling by CFTR. Science 256 (1992) 530-532
29. + channel (ENaCs) in Xenopus oocytes co-expressing CFTR and ENaC. J. Physiol. (London) 508 (1998) 825-836
30. + channel (ENaC) subunits in normal and cystic fibrosis airways. Am. J. Physiol. 269 (1995) C511-C518
31. Canessa C.M., Horisberger J.-D., and Rossier B.C. Epithelial sodium channel related to proteins involved in neurodegeneration. Nature (London) 361 (1993) 467-470
32. + channel is made of three homologous subunits. Nature (London) 367 (1994) 463-467
33. + channel regulation. Kidney Int. 48 (1995) 970-984
34. + channel activity. Am. J. Physiol. 261 (1991) C882-C888
35. Cherksey B.D. Functional reconstitution of an isolated sodium channel from bovine trachea. Comp. Biochem. Physiol. A 90 (1988) 771-773
36. Cherry R.J. Rotational and lateral diffusion of membrane proteins. Biochim. Biophys. Acta 559 (1979) 289-327
37. Chinet Fullton T.C., Yankaskas J.M.J.R., Boucher R.C., and Stutts M.J. Sodium-permeable channels in the apical membrane of human nasal epithelial cells. Am. J. Physiol. 265 (1993) C1050-C1060
38. Chinet Fullton T.C., Yankaskas J.M.J.R., Boucher R.C., and Stutts M.J. Mechanism of sodium hyperabsorption in cultured cystic fibrosis nasal epithelium: A patch-clamp study. Am. J. Physiol. 266 (1994) C1061-C1068
39. Collins F.S. Cystic fibrosis: Molecular biology and therapeutic implications. Science 256 (1992) 774-779
40. Cotton C.U., Lawson E.E., Boucher R.C., and Gatzy J.T. Bioelectric properties and ion transport of airways excised from adult and fetal sheep. J. Appl. Physiol. 55 (1983) 1542-1549
41. Cotton C.U., Stutts M.J., Knowles M.R., Gatzy J.T., and Boucher R.C. Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. An in vitro electrophysiologic analysis. J. Clin. Invest. 79 (1987) 80-85
42. Cotton C.U., Boucher R.C., and Gatzy J.T. Bioelectric properties and ion transport across excised canine fetal and neonatal airways. J. Appl. Physiol. 65 (1988) 2367-2375
43. Dean M., and Santis G. Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations. Hum. Genet. 93 (1994) 364-368
44. Dean M., White M.B., Amos J., Gerrard B., Stewart Khaw C.K.T., and Leppert M. Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients. Cell (Cambridge, Mass.) 61 (1990) 863-870
45. Delmarco A., Pradal U., Cabrini G., Bonizzato A., and Mastella G. Nasal potential difference in cystic fibrosis patients presenting borderline sweat test. Eur. Respir. J. 10 (1997) 1145-1149
46. Drumm M.L., Wilkinson D.J., Smit L.S., Worrell R.T., Strong T.V., Frizzell R.A., Dawson D.C., and Collins F.S. Chloride conductance expressed by F508 and other mutant CFTRs in Xenopus oocytes. Science 254 (1991) 1797-1799
47. Duszyk French M.A.S., and Man S.F. Cystic fibrosis affects chloride and sodium channels in human airway epithelia. Can. J. Physiol. Pharmacol. 67 (1989) 1362-1365
48. Edidin M. Rotational and lateral diffusion of membrane proteins and lipids: Phenomena and function. Curr. Top. Membr. Transp. 29 (1987) 91-127
49. Fahey P.F., and Webb W.W. Lateral diffusion in phospholipid bilayer membranes and multilamellar liquid crystals. Biochemistry 17 (1978) 3046-3053
50. + channel along rat respiratory tract. Am. J. Physiol. 272 (1997) C131-C141
51. Feng Z.P., Clark R.B., and Berthiaume Y. Identification of nonselective cation channels in cultured adult rat alveolar type II cells. Am. J. Respir. Cell. Mol. Biol. 9 (1993) 248-254
52. Ferrari M., and Cremonesi L. Genotype-phenotype correlation in cystic fibrosis patients. Ann. Biol. Clin. (Paris) 54 (1996) 235-241
53. Firsov D., Schild L., Gautschi I., Merillat A.M., Schneeberger E., and Rossier B.C. Cell surface expression of the epithelial Na channel and a mutant causing Liddle syndrome: A quantitative approach. Proc. Natl. Acad. Set. U.S.A. 93 (1996) 15370-15375
54. Firsov D., Gautschi I., Merillat A.M., Rossier B.C., and Schild L. The heterotetrameric architecture of the epithelial sodium channel (ENaC). EMBO J. 17 (1998) 344-352
55. Frizzell R.A. Functions of the cystic fibrosis transmembrane conductance regulator protein. Am. J. Respir. Crit. Care Med. 151 (1995) S54-S58
56. Fuller C.M., and Benos D.J. CFTR. Am. J. Physiol. 263 (1992) C267-C286
57. Gallo R.L. Aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N. Engl. J. Med. 323 (1990) 996-997 (Letter to the Editor)
58. Garty H., and Palmer L.G. Epithelial sodium channels: Function, structure and regulation. Physiol. Rev. 77 (1997) 359-396
59. Gowen C.W., Lawson E.E., Gingras-Leatherman J., Gatzy J.T., Boucher R.C., and Knowles M.R. Increased nasal potential difference and amiloride sensitivity in neonates with cystic fibrosis. J. Pediatr. 108 (1986) 517-521
60. - secretion in nasal epithelia of CF mice. Am. J. Physiol. 266 (1994) C1478-C1483
61. Hamosh A., and Cutting G.R. Genotype/phenotype relationships in cystic fibrosis. In: Dodge J.A., Brock D.J.H., and Widdicombe J.H. (Eds). "Cystic Fibrosis-Current Topics. 1 (1993), Wiley, Chichester 69-89
62. Hanrahan J.W., Tabcharani J.A., Becq F., Mathews C.J., Augustinas O., Jensen T.J., Chang X.B., and Riordan J.R. Function and dysfunction of the CFTR chloride channel. Soc. Gen. Physiol. Ser. 50 (1995) 125-137
63. Hansson J.H., Nelson-Williams Suzuki C., Schild H.L., Shimkets R., Lu Y., Canessa Iwasaki C., Rossier T.B., and Lifton R.P. Hypertension caused by a truncated epithelial sodium channel y subunit: Genetic heterogeneity of Liddle syndrome. Nat. Genet. 11 (1995) 76-82
64. Hansson Schild J.H., Lu L.Y., Wilson T., Gautschi I., Shimkets R., Nelson-Williams Rossier C.B., and Lifton R. A de novo missense mutation of the β subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc. Natl. Acad. Scio. U.S.A. 92 (1995) 11495-11499
65. Hay J.G., and Geddes D.M. Transepithelial potential difference in cystic fibrosis. Thorax 40 (1985) 493-496
66. Hay J.G., McElvaney N.G., Herena J., and Crystal R.G. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector. Hum. Gene Ther. 6 (1995) 1487-1496
67. Higgins C.F. Cystic fibrosis transmembrane conductance regulator (CFTR). Br. Med. Bull. 48 (1992) 754-765
68. -) conductance. FEBS Lett. 374 (1995) 312-316
69. Ho L.P., Samways J.M., Porteous D.J., Dorin J.R., Carothers A., Greening A.P., and Innes J.A. Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosis. Eur. Respir. J. 10 (1997) 2018-2022
70. Hummler E., Barker P., Gatzy J., Beermann F., Verdumo Schmidt C., Boucher A.R., and Rossier B.C. Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. Nat. Genet. 12 (1996) 325-328
71. + channel. J. Biol. Chem. 271 (1996) 807-816
72. Ismailov I.I., Awayda M.S., Jovov B., Berdiev B.K., Fuller C.M., Dedman J.R., Kaetzel M., and Benos D.J. Regulation of epithelial sodium channels by the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 271 (1996) 4725-4732
73. Ismailov I.I., Berdiev B.K., Shlyonsky V.G., Fuller C.M., Prat A.G., Jovov B., Cantiello H.F., Ausiello D.A., and Benos D.J. Role of actin in regulation of epithelial sodium channels by CFTR. Am. J. Physiol. 272 (1997) C1077-C1086
74. Jefferson D.M., Valentich J.D., Marini Grubman F.C., Iannuzzi S.A., Dorkin M.C., Li H.L.M., Klinger K.W., and Welsh M.J. Expression of normal and cystic fibrosis phenotypes by continuous airway epithelial cell lines. Am. J. Physiol. 259 (1990) L496-L505
75. Jilling T., and Kirk K.L. The biogenesis, traffic, and function of the cystic fibrosis transmembrane conductance regulator. Int. Rev. Cytol. 172 (1997) 193-241
76. Jorissen M., Vereecke J., Carmeliet E., Van den Berghe H., and Cassiman J.J. Identification of a voltage- and calcium-dependent non-selective cation channel in cultured adult and fetal human nasal epithelial cells. Pfluegers Arch. 415 (1990) 617-623
77. Jovov B., Ismailov I.I., and Benos D.J. Cystic fibrosis transmembrane conductance regulator is required for protein kinase A activation of an outwardly rectified anion channel purified from bovine tracheal epithelia. J. Biol. Chem. 270 (1995) 1521-1528
78. Kiesewetter S., Macek Jr. M., Davis Curristin C., Chu S.M.C.S., Graham Shrimpton C., Cashman A.E.S.M., Tsui Mickle L.C., Amos J.J., Highsmith W.E., Shuber A., Witt D.R., Crystal R.G., and Cutting G.R. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat. Genet. 5 (1993) 274-278
79. Knowles M.R., Carson J.L., Collier A.M., Gatzy J.T., and Boucher R.C. Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo. Am. Rev. Respire. Dis. 124 (1981) 484-490
80. Knowles M., Gatzy J., and Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N. Engl. J. Med. 305 (1981) 1489-1495
81. Knowles M.R., Buntin W.H., Bromberg P.A., Gatzy J.T., and Boucher R.C. Measurements of transepithelial electric potential differences in the trachea and bronchi of human subjects in vivo. Am. Rev. Respire. Dis. 126 (1982) 108-112
82. Knowles M., Gatzy J., and Boucher R. Relative ion permeability of normal and cystic fibrosis nasal epithelium. J. Clin. Invest. 71 (1983) 1410-1417
83. Knowles M.R., Stutts M.J., Spock A., Fischer N., Gatzy J.T., and Boucher R.C. Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science 221 (1983) 1067-1070
84. Knowles M., Murray G., Shallal J., Askin F., Ranga V., Gatzy J., and Boucher R. Bioelectric properties and ion flow across excised human bronchi. J. Appl. Physiol. 56 (1984) 868-877
85. Knowles M.R., Church N.L., Waltner W.E., Yankaskas J.R., Gilligan P., King M., Edwards L.J., Helms R.W., and Boucher R.C. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N. Engl. J. Med. 322 (1990) 1189-1194
86. Knowles M.R., Church N.L., Waltner W.E., Yankaskas J.R., Gilligan P., King M., Edwards L.J., Helms R.W., and Boucher R.C. Aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N. Engl. J. Med. 323 (1990) 997-998
87. Knowles M.R., Church N.L., Waltner W.E., Gatzy J.T., and Boucher R.C. Amiloride in cystic fibrosis: Safety, pharmacokinetics, and efficacy in the treatment of pulmonary disease. In: Cragoe Jr. E.J., Kleyman T.R., and Simchowitz L. (Eds). "Amiloride and Its Analogs: Unique Cation Transport Inhibitors" (1992), VCH Publishers, New York 301-316
88. Knowles M.R., Paradiso A.M., and Boucher R.C. Vivo nasal potential difference: Techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum. Gene Ther. 6 (1995) 445-455
89. Knowles M.R., Olivier K., Noone P., and Boucher R.C. Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis. Am. J. Respir. Crit. Care Med. 151 (1995) S65-S69
90. Koefoed-Johnson V., and Ussing H.H. The nature of the frog skin potential. Acta Physiol. Scand. 42 (1958) 298-308
91. Kohler D., App E., Schmitz-Schumann M., Wurtemberger G., and Matthys H. Inhalation of amiloride improves the mucociliary and the cough clearance in patients with cystic fibroses. Eur. J. Respir. Dis., Suppl. 146 (1986) 319-326
92. Kosari F., Sheng S., Li J., Mak D.O., Foskett J.K., and Kleyman T.R. Subunit stoichiometry of the epithelial sodium channel. J. Biol. Chem. 273 (1998) 13469-13474
93. + conductance in cystic fibrosis. Pfleugers Arch. 431 (1995) 1-9
94. + conductances in airway epithelial cells. Pfluegers Arch. 431 (1996) 578-586
95. + currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator. FEBS Lett. 400 (1997) 341-344
96. + channels in mouse CCD cells. Am. J. Physiol. 272 (1997) C657-C666
97. Lifton R.P. Molecular genetics of human blood pressure variation. Science 272 (1996) 676-680
98. Ling B.N., Zuckerman J.B., Lin Harte C., McNulty B.J.K.A., Smith P.R., Gomez L.M., Worrell R.T., Eaton D.C., and Kleyman T.R. Expression of the cystic fibrosis phenotype in a renal amphibian epithelial cell line. J. Biol. Chem. 272 (1997) 594-600
99. + channel. A new channel type with homologies to Caenorhabditis elegans degenerins. FEBS Lett. 318 (1993) 95-99
100. + channels in fetal type II pneumocytes are regulated by G proteins. Am. J. Physiol. 267 (1994) L1-L8
101. + conductance when coexpressed in Xenopus oocytes. FEBS Lett. 381 (1996) 47-52
102. + conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways. J. Clin. Invest. 102 (1998) 15-21
103. Matsushita K., McCray Jr. P.B., Sigmund R.D., Welsh M.J., and Stokes J.B. Localization of epithelial sodium channel subunit mRNAs in adult rat lung by in situ hybridization. Am. J. Physiol. 271 (1996) L332-L339
104. Mearns M.B. Cystic fibrosis: The first 50 years. A review of the clinical problems and their management. In: Dodge J.A., Brock D.J.H., and Widdicombe J.H. (Eds). "Cystic Fibrosis-Current Topics. 1 (1993), Wiley, Chichester 217-250
105. Middleton P.G., Geddes D.M., and Alton E.W. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects. Thorax 48 (1993) 812-816
106. Middleton P.G., Geddes D.M., and Alton E.W. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur. Respir. J. 7 (1994) 2050-2056
107. Miller P.W., Hamosh A., Macek Jr. M., Greenberger P.A., MacLean J., Walden S.M., Slavin R.G., and Cutting G.R. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am. J. Hum. Genet. 59 (1996) 45-51
108. Orser B.A., Bertlik M., Fedorko L., and O'Brodovich H. Cation selective channel in fetal alveolar type II epithelium. Biochim. Biophys. Ada 1094 (1991) 19-26
109. Peters R., and Cherry R.J. Lateral and rotational diffusion of bacteriorodopsin in lipid bilayers: Experimental test of the Saffman-Delbruck equations. Proc. Nat. Acad. Sci. U.S.A. 79 (1982) 4317-4321
110. + channels by protein kinase A requires actin filaments. Am. J. Physiol. 265 (1993) C224-C233
111. Quinton P.M. Cystic fibrosis: A disease in electrolyte transport. FASEB J. 4 (1990) 2709-2717
112. Quinton P.M., and Bijman J. Higher bioelectric potentials due to decreased chloride absorption in the sweat glands of patients with cystic fibrosis. N. Engl. J. Med. 308 (1983) 1185-1189
113. + channel in colon, lung and kidney. Pfluegers Arch. 430 (1995) 299-307
114. Riordan J.R. The cystic fibrosis transmembrane conductance regulator. Annu. Rev. Physiol. 55 (1993) 609-630
115. + channels. Biochem. Biophys. Res. Commun. 237 (1997) 488-491
116. Saffman P.G., and Delbrück M. Brownian motion in biological membranes. Proc. Natl. Acad. Sci. U.S.A. 72 (1975) 3111-3113
117. Sauder R.A., Chesrown S.E., and Loughlin G.M. Clinical application of transepithelial potential difference measurements in cystic fibrosis. J. Pediatr. 111 (1987) 353-358
118. + channel protein into planar lipid bilayers. Am. J. Physiol. 268 (1995) C1148-C1156
119. -) channels with altered pore properties. Nature (London) 362 (1993) 160-164
120. Shimkets R.A., Lifton R., and Canessa C.M. Vivo phosphorylation of the epithelial sodium channel. Proc. Natl. Acad. Scio. U.S.A. 95 (1998) 3301-3305
121. Smith P.R., Stoner Viggiano L.C., Angelides S.C.K.J., and Benos D.J. Effect of vasopressin and aldosterone on the lateral mobility of epithelial Na channels in A6 renal epithelial cells. J. Membr. Biol. 147 (1995) 195-205
122. Snyder P.M., Price M.P., McDonald F.J., Adams C.M., Volk K.A., Zeiher B.G., Stokes J.B., and Welsh M.J. Mechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na channel. Cell (Cambridge, Mass.) 83 (1995) 969-978
123. Snyder P.M., Cheng Prince C., Rogers L.S.J.C., and Welsh M.J. Electrophysiological and biochemical evidence that DEG/ENaC cation channels are composed of nine subunits. J. Biol. Chem. 273 (1998) 681-684
124. Stutts M.J., Canessa C.M., Olsen Hamrick J.C., Cohn M.J.A., Rossier B.C., and Boucher R.C. CFTR as a cAMP-dependent regulator of sodium channels. Science 269 (1995) 847-850
125. Stutts M.J., Rossier B.C., and Boucher R.C. Cystic fibrosis transmembrane conductance regulator inverts protein kinase A- mediated regulation of epithelial sodium channel single channel kinetics. J. Biol. Chem. 272 (1997) 14037-14040
126. Tohda H., and Marunaka Y. Insulin-activated amiloride-blockable nonselective cation and NaH channels in the fetal distal lung epithelium. Gen. Pharmacol. 26 (1995) 755-763
127. Tomkiewicz R.P., App E.M., Zayas J.G., Ramirez O., Church N., Boucher Knowles R.C.M.R., and King M. Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum. Am. Rev. Respir. Dis. 148 (1993) 1002-1007
128. Tsui L.-C., and Buchwald M. Biochemical and molecular genetics of cystic fibrosis. Adv. Hum. Genet. 20 (1991) 153-166
129. Tsui L.-C., Markiewics D., Zielenski J., Corey M., and Durie P. Mutation analysis in cystic fibrosis. In: Dodge J.A., Brock D.J.H., and Widdicombe J.H. (Eds). "Cystic Fibrosis-Current Topics. 1 (1993), Wiley, Chichester 27-44
130. + channel: Biophysical properties, pharmacology, ontogenesis, and molecular cloning. Proc. Natl. Acad. Scio. U.S.A. 91 (1994) 247-251
131. Welsh M.J., and Smith A.E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell (Cambridge, Mass.) 73 (1993) 1251-1254
132. Widdicombe J.H., and Welsh M.J. Anion selectivity of the chloride-transport process in dog tracheal epithelium. Am. J. Physiol. 239 (1980) C112-C117
133. Willumsen N.J., and Boucher R.C. Sodium transport and intracellular sodium activity in cultured human nasal epithelium. Am. J. Physiol. 261 (1991) C319-C331
134. Willumsen N.J., and Boucher R.C. Transcellular sodium transport in cultured cystic fibrosis human nasal epithelium. Am. J. Physiol. 261 (1991) C332-C341
135. Yamaya M., Finkbeiner W.E., Chun S.Y., and Widdicombe J.H. Differentiated structure and function of cultures from human tracheal epithelium. Am. J. Physiol. 262 (1992) L713-L724
136. Yankaskas J.R., Cotton C.U., Knowles M.R., Gatzy J.T., and Boucher R.C. Culture of human nasal epithelial cells on collagen matrix supports. A comparison of bioelectric properties of normal and cystic fibrosis epithelia. Am. Rev. Respir. Dis. 132 (1985) 1281-1287
137. Yankaskas J.R., Knowles M.R., Gatzy J.T., and Boucher R.C. Persistence of abnormal chloride ion permeability in cystic fibrosis nasal epithelial cells in heterologous culture. Lancet 1 (1985) 954-956
138. Yankaskas J.R., Stutts M.J., Cotton C.U., Knowles M.R., Gatzy J.T., and Boucher R.C. Cystic fibrosis airway epithelial cells in primary culture: Disease-specific ion transport abnormalities. Prog. Clin. Biol. Res. 254 (1987) 139-149
139. Yue G., Hu P., Oh Y., Jilling T., Shoemaker R.L., Benos D.J., Cragoe Jr. E.J., and Matalon S. Culture-induced alterations in alveolar type II cell Na+ conductance. Am. J. Physiol. 265 (1993) C630-C640
140. Yue G., Shoemaker R.L., and Matalon S. Regulation of low-amiloride-affinity sodium channels in alveolar type II cells. Am. J. Physiol. 267 (1994) L94-L100